Small Cap Voice

SmallCapVoice.com Inc. (“SCV”) announces the availability of an interview with Greg Reimer, newly appointed Chairman of the Board to Canadian cobalt exploration company Fuse Cobalt Inc. (“the Company” or “Fuse”) (TSXV:FUSE, OTCQB:FUSEF FRA:43W3) and current CEO of Surge Battery Metals Inc.

Speaking with SCV’s Stuart Smith, Reimer gives a quick review of Fuse and how his professional background is complementary to the Company’s business model and growth track.

“I've had a lot to do with mining policy and operations, as well as energy. I'm well-suited for this field and look forward to serving on the board,” he says, then moving to discussion of Fuse’s Glencore and Teledyne properties.

“A significant increase in cobalt prices has given the Company the ability to refocus and plan for our 2022 exploration program … These two projects have high cobalt intersections that were identified in previous drilling programs and we're currently securing drilling resources for a fall drilling program.”

Reimer also gives insight into the broader battery metals market and discusses increasing demand for electric vehicles and battery-powered consumer products.

Business Warrior Leadership Discusses Acquisition of FinTech SaaS Company, Alchemy Technologies

Business Warrior Corp. (OTC: BZWR), the source for small businesses in America to get more customers, today announces the acquisition of Alchemy Technologies, a global FinTech software as a service (SaaS) company. The acquisition strengthens Business Warrior’s core marketing and lending software while expanding the Company’s brand and services to meet global demand.

Alchemy specializes in creating end-to-end, cloud native lending experiences for other FinTech companies, merchants and banks. The company installs its core solution to a number of different verticals, including:

Personal loans

Point of Sale Financing

Health and Beauty Financing

Construction Loans

Solar and Home Improvement Financing

Small Business Lending

Skillset Financing

Crowdfunding Platforms

In working with Alchemy to develop its Business Warrior Funding lending platform earlier this year, Business Warrior identified Alchemy as an attractive acquisition opportunity, noting its operational and financial performance.

IIOT-OXYS, Inc. Leadership Conduct New Audio Interview Answering Shareholder Questions and Provide Overview of Recent Financial and Operational Results

IIOT-OXYS, Inc. (OTC PINK:ITOX) (“the Company”) announced it has conducted an audio interview to discuss its recent financial results, answer shareholder questions and provide an operational outlook moving forward.

IIOT-OXYS, Inc. leadership CEO, Cliff Emmons, and COO, Karen McNemar, who also fill the roles of interim CTO and interim CFO respectively, each provided their personal insights into recent news and business operations. Furthermore, each of them fielded several questions submitted to Company by its shareholders.

CEO Mike of O’Shea of Xcelerate, Inc., a development stage startup focused on the development of cutting-edge medtech applications, met with SmallCapVoice.com to discuss the recent appointment of a new board member and the acquisition of a rather sizeable patent portfolio.

This acquisition expands upon Xcelerate’s mission of acquiring innovation in the engineering and patent stages of production for further development and commercialization within the medical industry.

O’Shea was joined by Jon Wilken, president and CEO of HS Pharmaceuticals, LLC. They opened up about his new role as an advisory board member for Xcelerate and what has led up to the acquisition to this point.

Wilken spent more than 30 years in the supermarket retail industry before leaving the business in 2002. He also spent more than 10 years teaching entrepreneurial leadership at Clemson University. Venturing into the biopharmaceuticals industry, he then left academia and accepted the role as CEO and president of HS Pharmaceuticals, where he led the charge in the discovery of many early-stage drugs and immunotherapies.

As CEO of HS Pharmaceuticals, Wilken would focus on innovative and breakthrough treatments for chronic wounds and conditions that affect the human body on a molecular level, creating dermatological products for chronic wounds, burns, and drug-resistant infections, as well as patented formulas for some of the most game-changing cosmetics and beauty products on the market.

Throughout the years, the company would also focus on oncology, autoimmune therapies, cancer treatment and bone regeneration for both man and animal – many of which would be developed in collaboration with scientists at the Lakehead and Cambridge Universities.

In a previous press release, O’Shea stated that "HS Pharmaceuticals has been shepherding these patents for the last 10+ years in conjunction with world-renowned scientists and universities, and we are excited to take this amazing intellectual property to the next level."

"The Board and I welcome Jon,” he continued, “and look forward to collaborating with him on the various projects and, more especially, assisting in assimilating the recently acquired patent portfolio into our business plan. Jon has spent years coordinating the development of these patents and coordinating the efforts of various research scientists and universities."

For the last 2 years, both companies have been in negotiation, making sure the climate was suitable when merging HS Pharmaceuticals into the fold of Xcelerate and its growing list of revolutionary technologies.

Since announcing that it had signed a purchase agreement to acquire a global portfolio of patents, patents pending, and technology licenses from HS Pharmaceuticals LLC, Xcelerate would go on to add a number of patents and patents pending across the U.S., Canada and Eurasia, which can be found here.

“We're excited that we're excited about this relationship with Mike and his team,” states Wilken. “We're looking forward to our scientists, our research people, our PhDs working with the people that Mike has on board. It's going to be a great collaboration.”

Xcelerate plans on taking the research conducted by HS Pharmaceuticals and its entire portfolio of patents to the next level. Together, the companies have devised a plan that is expected to become of great interest to major pharmaceutical houses across the industry.

MIAMI, FL, May 17, 2022 (GLOBE NEWSWIRE) -- via – Progressive Care Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced financial and operational results for the three months ended March 31, 2022.

Key Financial Highlights for the Three Months Ended March 31, 2022 compared to the same period in 2021

Revenue increased by 5%, from $9.6 million in 2021 to $10.1 million in 2022

Gross margin decreased slightly to 24% in 2022 from 25% in 2021

Operating loss decreased by 79%, from $0.6 million in 2021 to $0.1 million in 2022

Adjusted EBITDA increased by 53% from $66,349 in 2021 to $101,646 in 2022

Business Highlights

Strengthened management team with industry experts

Expanded corporate services with enhanced COVID-19 platform capabilities

Approved as COVID-19 test vendor in the U.S. for travel to Beijing Winter Olympic Games

Engaged with Alteryx software implementation partner Aimpoint Digital to streamline healthcare data management workflows.

Partnered with Podium to boost customer satisfaction, efficiency and brand awareness

Gained long-term pharmacy contracts with major payors

Announced expansion plans into the rapidly growing multi-billion dollar Remote Patient Monitoring space

Gained SEC reporting status on April 11, 2022 through the filing of Form 10-12G Summary Financials for the Three Months

Ended March 31, 2022, as Compared with the Three Months Ended March 31, 2021

SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Arman Tabatabaei, CEO Cannabis Global Inc. (OTC Pink: CBGL), to address questions from the Company’s shareholders and the investment community.

Speaking with SCV’s Stuart Smith, Tabatabaei discusses the challenges associated with corporate growth, keeping up with regulatory changes, and fund raising. In conjunction with all of CBGL’s progress, Tabatabaei believes transparency with shareholders is crucial.

“Right now, our main challenge is managing growth and I think that's a good of a problem to have,” he says. “We're growing very quickly, and we're caught between financing the business, hiring adequate personnel, managing the distribution channel. And you know, of course the regulatory environment that is inherit to the cannabis industry … We've been fortunate to receive adequate financing thus far, but in a nutshell, I will tell you that our biggest challenge is to manage the growth relative to raising capital so we can ensure that we can meet our goals.”

The interview touches on a sweeping range of topics to keep shareholders abreast of CBGL’s corporate developments. As the Company continues its growth trajectory, Tabatabaei says he plans to hold more Q&A sessions and concludes the interview by welcoming investors and shareholders to send additional questions to SSmith@SmallCapVoice.

Marc Hazout, Founder, Chairman and Chief Executive Officer of SusGlobal Energy Corp. ("SUSGLOBAL" or the "Company") (OTCQB: SNRG), the developer of SusGro™, an award-winning, revolutionary pathogen-free organic liquid fertilizer, called into SmallCapVoice.com, to discuss the recent news and milestones for the Company. Recently, SusGlobal announced that its wholly-owned subsidiary, SusGlobal Energy Hamilton Ltd. ("SusGlobal Hamilton"), continues the development of its 51,535 square foot facility on 3.26 acres (the "Property") located at 520 Nash Road North, in Hamilton, Ontario, which includes an Environmental Compliance Approval ("ECA") to process up to 65,884 metric tonnes per annum of organic waste into regenerative products as part of the Company's circular economy model and continued climate change initiatives

Earlier this year, the Company announced that its wholly-owned subsidiary, SusGlobal Energy Canada Corp. ("SusGlobal Canada"), has entered into a non-binding letter of intent to acquire a soil media, plant nutrients, and amendments producer approved for organic use and specifically formulated for producing high-quality fruit and flowering crops (the "Target") for an aggregate purchase price of US$15,701,885 (CA$20,000,000) (the "Acquisition").

SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Michael O’Shea, CEO of Xcelerate, Inc. (OTC Pink: XCRT) and Dr. Dilan Ellegala Xcelerate Advisory Board Member and co-founder of AfiyaSasa Africa, LLC ("ASA). The interview covers the Xcelerate announced has acquired majority control in AfiyaSasa Africa, LLC. ("ASA"), a medical technology and virtual health company that they believe is positioned to help patients in developing countries in Africa meet their medical needs by extending the reach of physicians and hospitals through the Company's technology. Dr. Dilan Elegalla, one of the Managers of this LLC, has relocated to Tanzania to establish a pilot program for the ASA System in that country. XCRT is now excited to announce that, thanks to the efforts of Dr. Elegalla and his team, ASA now has verbal commitments to launch AfiyaSasa Tanzania as a pilot in 4 hospitals and likely in a fifth: KCMC (Kilimanjaro Christian Medical Centre). NSK Hospitals, ALMC (Arusha Lutheran Medical Center), and Haydon Lutheran Hospital. These four institutions represent a catchment area of approximately 20 million people. Once the pilot program is established and tested, they would continue with a rollout into the institution as well as their outreach clinics. A fifth hospital, Jakaya Kikwete Cardiac Institute, has expressed a strong interest in joining the pilot program. JKCI is a specialty hospital with countrywide reach (60 million Tanzanians plus regional patients).

Progressive Care is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Monday, March 28, 2022.

MIAMI, FL, March 23, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company (the “Company” or “Progressive Care”), is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Monday, March 28, 2022.

Chairman and CEO, Alan Jay Weisberg, stated, “I believe 2021 was a challenging year for Progressive Care. Our team was able to complete complex implementation of the pharmacy system so that the company can get back to growing the pharmacy business, successfully achieve record COVID-19 revenues and position itself to become an SEC reporting company. We are looking forward to providing our shareholders with a more detailed update and share the Company’s vision for 2022 during the conference call.”

SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Travis Crane of WarpSpeed Taxi Inc. (OTC Pink: WRPT) (“WarpSpeed” or the “Company”), the developer of an all-in-one software solution for ride hailing, food delivery, and courier services, to discuss how the Company is executing on an aggressive five-year plan for market penetration in several key countries before global expansion.

WarpSpeed Taxi came from the desire to simplify and consolidate several consumer services into an ‘All-in-one’ application. They have taken a ride-sharing service and combined it with local food and grocery delivery services plus additional courier services. Thereby, customers can delete 3 or 4 different services and just use one, whose focus is efficiency and speed.

“As far as the business model, we’ve set this up so we can enter the market as quickly as possible. Right now, the app is in beta testing and doing quite well in testing actually. We decided to start testing where there’s a significant need for this too, Ahmedabad, India. Once we’re confident in the application and we’ve taken care of any UX issues, we’re planning a full-scale launch in India. After that, we’re targeting Kenya. The big key here is localized branding and advertising, in India, we’re called Tezi Taxi, which is Hindi for Fast Taxi. When we launch in Kenya, it’ll be Haraka Taxi, which translates to Quickly in Swahili. The goal is to provide a localized, on-brand experience everywhere!” Crane says. “I would say our biggest goal at our doorstep is completing that Beta test and launching full scale. We really want to make an impact to what happened during the Covid-19 pandemic. See a lot of restaurants had to rely on delivery services, but they’re currently being charged up to 30% of the ticket price each time. Our business model allows taxi drivers to deliver food, groceries, and more, but instead of charging ridiculous fees, we’re basing delivery on distance traveled. This should keep costs as low as possible to restaurants and other vendors in the areas.”

The interview also highlights several corporate milestones such as moving the Company toward uplisting to the OTCQB and penetrating the US market later in 2022.